GLAXOSMITHKLINE PHARMACEUTICALS LTD.

NSE : GLAXOBSE : 500660ISIN CODE : INE159A01016Industry : Pharmaceuticals & DrugsHouse : Glaxosmithkline - MNC
BSE1868.85-20.35 (-1.08 %)
PREV CLOSE ( ) 1889.20
OPEN PRICE ( ) 1856.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3765
TODAY'S LOW / HIGH ( )1846.25 1879.15
52 WK LOW / HIGH ( )1228 2649.95
NSE1871.20-16.95 (-0.9 %)
PREV CLOSE( ) 1888.15
OPEN PRICE ( ) 1878.15
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1871.20 (502)
VOLUME 49219
TODAY'S LOW / HIGH( ) 1854.00 1878.20
52 WK LOW / HIGH ( )1227 2524
Peer Companies Price () Chg () Chg (%) EPS () TTM P/E Volume (000's) 1 Year Return (%)

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.